drugset / Trial / NCT02955030
Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of a sublingual administration of NSV0001 in healthy male volunteers.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-03
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Biken HA | Vaccine | — | Subcutaneous |
| Subject | NSV0001 | Vaccine | 15 ug | Other |
| Subject | NSV0001 | Vaccine | 30 ug | Other |
| Subject | NSV0001 | Vaccine | 60 ug | Other |